Literature DB >> 28382584

A survey of attitudes, practices, and knowledge regarding drug-drug interactions among medical residents in Iran.

Ehsan Nabovati1,2, Hasan Vakili-Arki3, Zhila Taherzadeh4,5, Mohammad Reza Saberi6, Ameen Abu-Hanna7, Saeid Eslami8,9,10.   

Abstract

Background When prescribing medications, physicians should recognize clinically relevant potential drug-drug interactions (DDIs). To improve medication safety, it is important to understand prescribers' knowledge and opinions pertaining to DDIs. Objective To determine the current DDI information sources used by medical residents, their knowledge of DDIs, their opinions about performance feedback on co-prescription of interacting drugs. Setting Academic hospitals of Mashhad University of Medical Sciences (MUMS) in Iran. Methods A questionnaire containing questions regarding demographic and practice characteristics, DDI information sources, ability to recognize DDIs, and opinions about performance feedback was distributed to medical residents of 22 specialties in eight academic hospitals in Iran. We analyzed their perception pertaining to DDIs, their performance on classifying drug pairs, and we used a linear regression model to assess the association of potential determinants on their DDI knowledge. Main Outcome Measure prescribers' knowledge and opinions pertaining to DDIs. Results The overall response rate and completion rate for 315 distributed questionnaires were 90% (n = 295) and 86% (n = 281), respectively. Among DDI information sources, books, software on mobile phone or tablet, and Internet were the most commonly-used references. Residents could correctly classify only 41% (5.7/14) of the drug pairs. The regression model showed no significant association between residents' characteristics and their DDI knowledge. An overwhelming majority of the respondents (n = 268, 95.4%) wished to receive performance feedback on co-prescription of interacting drugs in their prescriptions. They mostly selected information technology-based tools (i.e. short text message and email) as their preferred method of receiving feedback. Conclusion Our findings indicate that prescribers may have poor ability to prevent clinically relevant potential DDI occurrence, and they perceive the need for performance feedback. These findings underline the importance of well-designed computerized alerting systems and delivering performance feedback to improve patient safety.

Entities:  

Keywords:  Drug–drug interaction; Information sources; Iran; Medication knowledge; Performance feedback; Prescribers’ attitude

Mesh:

Year:  2017        PMID: 28382584     DOI: 10.1007/s11096-017-0453-3

Source DB:  PubMed          Journal:  Int J Clin Pharm


  36 in total

Review 1.  Herbal, prescribed, and over-the-counter drug use in older women: prevalence of drug interactions.

Authors:  Saunjoo L Yoon; Susan D Schaffer
Journal:  Geriatr Nurs       Date:  2006 Mar-Apr       Impact factor: 2.361

2.  Impact of a drug-drug interaction intervention on pharmacy and medical students' knowledge and attitudes: a 1-year follow-up.

Authors:  Ana L Hincapie; Terri L Warholak; Lisa E Hines; Ann M Taylor; Daniel C Malone
Journal:  Res Social Adm Pharm       Date:  2012-01-04

3.  Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care.

Authors:  M L Andersson; Y Böttiger; J D Lindh; B Wettermark; B Eiermann
Journal:  Eur J Clin Pharmacol       Date:  2012-07-01       Impact factor: 2.953

4.  Physician's expectations regarding prescribing clinical decision support systems in a Belgian hospital.

Authors:  P Cornu; S Steurbaut; M De Beukeleer; K Putman; R van de Velde; A G Dupont
Journal:  Acta Clin Belg       Date:  2014-03-13       Impact factor: 1.264

5.  Drug-drug interactions among elderly patients hospitalized for drug toxicity.

Authors:  David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

6.  Diffusion of Technology: Frequency of Use for Younger and Older Adults.

Authors:  Katherine E Olson; Marita A O'Brien; Wendy A Rogers; Neil Charness
Journal:  Ageing Int       Date:  2011-03

7.  Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.

Authors:  Hossein Khalili; Iman Karimzadeh; Parastoo Mirzabeigi; Simin Dashti-Khavidaki
Journal:  Eur J Intern Med       Date:  2012-12-12       Impact factor: 4.487

8.  Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.

Authors:  Dima M Qato; G Caleb Alexander; Rena M Conti; Michael Johnson; Phil Schumm; Stacy Tessler Lindau
Journal:  JAMA       Date:  2008-12-24       Impact factor: 56.272

9.  Impact of educational intervention on the pattern and incidence of potential drug-drug interactions in Nepal.

Authors:  Durga Bista; Archana Saha; Pranaya Mishra; Subish Palaian; Pathiyil R Shankar
Journal:  Pharm Pract (Granada)       Date:  2009-03-15

Review 10.  Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature.

Authors:  Ehsan Nabovati; Hasan Vakili-Arki; Zhila Taherzadeh; Mohammad Reza Hasibian; Ameen Abu-Hanna; Saeid Eslami
Journal:  Daru       Date:  2014-06-25       Impact factor: 3.117

View more
  3 in total

Review 1.  Pharmacological Interactions in the Elderly.

Authors:  Emilia Błeszyńska; Łukasz Wierucki; Tomasz Zdrojewski; Marcin Renke
Journal:  Medicina (Kaunas)       Date:  2020-06-28       Impact factor: 2.430

2.  Concurrent prescribing: Evaluation of its knowledge among dentists.

Authors:  Amit Sharma; Kopal Sharma; Kanu Neemawat; Lokendra Sharma; Dinesh Pilania
Journal:  Natl J Maxillofac Surg       Date:  2019 Jan-Jun

3.  Designing and evaluating contextualized drug-drug interaction algorithms.

Authors:  Eric Chou; Richard D Boyce; Baran Balkan; Vignesh Subbian; Andrew Romero; Philip D Hansten; John R Horn; Sheila Gephart; Daniel C Malone
Journal:  JAMIA Open       Date:  2021-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.